Countries other than the U.S
Join Mayo Clinic Diet to start your own health journey today
For patients considering compounded GLP-1 options like semaglutide or tirzepatide through PlexusDx, understanding your individual risk profile before treatment starts supports safer, more personalized care
Retrieved 26 February 2021, from Lipodystrophy study halted after patient death
Other reactions that occurred at a higher incidence among WEGOVY-treated adult patients included dyspepsia, abdominal pain, abdominal distension, eructation, flatulence, gastroesophageal reflux disease, gastritis, hemorrhoids, and hiccups
Industry analysts increasingly view delivery innovation as potentially as consequential as efficacy improvements